从2013年到2024年,对碳醇及其衍生物作为抗癌剂的审查
Priyanka Sanjay Waghmare1, Anuruddha Rajaram Chabukswar1, Kunal Ganesh Raut1
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Chirality
|January 31, 2025
概括
碳醇衍生物显示出作为抗癌剂的前景,提供新的治疗策略. 本综述详细介绍了它们的机制,结构-活性关系以及改善癌症治疗的化学预防潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 几十年来,碳醇类化合物已经显示出抗癌性质.
- 现有的癌症疗法具有显著的副作用和低于最佳的结果.
- 迫切需要新的,更安全,更有效的抗癌药物.
研究的目的:
- 对抗癌症潜力的碳醇衍生物和混合复合材料进行审查.
- 阐明它们的受体相互作用和作用机制.
- 总结结构-活性关系 (SAR) 和化学预防应用.
主要方法:
- 关于碳醇衍生物和混合复合材料的文献综述.
- 对抗癌症机制和受体相互作用的分析.
- 评估结构-活性关系和化学预防作用.
主要成果:
- 许多碳醇衍生物具有强大的抗癌活性.
- 特定的衍生品显示出与各种癌症相关受体的有希望的相互作用.
- 结构-活性关系研究指导新抗癌剂的设计.
结论:
- 碳醇衍生物代表了一类有价值的化合物,用于癌症治疗和化疗预防.
- 需要进一步的研究和临床开发才能获得FDA的批准.
- 本综述提供了对基于卡巴佐尔的抗癌药物发现的最新见解.
相关概念视频
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


